Clinical Trials Sponsored by Health Insight

Total 50532 results

OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms | Unusual Cancers of Childhood

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Lymphoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML

Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy

Breast Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms | Nausea and Vomiting

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma (Protocol-A)

Lymphoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Prostate Cancer
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

Unspecified Adult Solid Tumor, Protocol Specific | Infection

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Stage IIA Adult Soft Tissue Sarcoma | Stage IIB Adult Soft Tissue Sarcoma | Stage IIC Adult Soft Tissue Sarcoma
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Lymphoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Sarcoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers

Myelodysplastic Syndromes | Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Tissue Sample Collection From Patients With Fanconi Anemia

Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Fanconi Anemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation Therapy

Prostate Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (Bu Flu TBI)

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Myelodysplastic/Myeloproliferative Neoplasms

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Docetaxel in Treating Patients With Relapsed Prostate Cancer

Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer

Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer

Fatigue | Hot Flashes | Prostate Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Breast Cancer | Brain and Central Nervous System Tumors | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment | Drug/Agent Toxicity by Tissue/Organ
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Brain and Central Nervous System Tumors | Long-term Effects Secondary to Cancer Therapy in Children | Drug/Agent Toxicity by Tissue/Organ | Bone Marrow Suppression

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

Leukemia

United States
OHSU Knight Cancer Institute
American Cancer Society, Inc.

Completed

Optimizing Body Composition & Health After Breast Cancer

Breast Neoplasm | Osteoporosis, Postmenopausal

United States
OHSU Knight Cancer Institute
Genentech, Inc.; OSI Pharmaceuticals

Terminated

Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Leukemia

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

Prostate Cancer
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer

Breast Cancer | Osteoporosis | Menopausal Symptoms

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Imatinib Mesylate in Treating Patients With Myelofibrosis

Chronic Myeloproliferative Disorders

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Leukemia

United States
Center For Sight
Science in Vision

Completed

Symfony/Synergy IOL Combination Outcomes

Presbyopia | Bilateral Cataract

United States
Center For Sight
Science in Vision

Completed

Synergy Lens Outcomes Evaluation

Presbyopia | Pseudophakia

United States
Mayo Clinic
Second Sight Medical Products

Completed

Argus II/ORCAM Device Study

Retinitis Pigmentosa

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Agency for Healthcare Research and Quality...

Recruiting

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Breast Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University; Weill...

Recruiting

Feasibility of FMISO in Brain Tumors

Malignant Brain Neoplasm

United States
OHSU Knight Cancer Institute
Merck Sharp & Dohme LLC; Oregon Health and Science University; Collins Medical...

Active, not recruiting

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Castration-Resistant Prostate Carcinoma | Recurrent Prostate Carcinoma | PSA Progression | Hormone-Resistant Prostate Cancer | Stage IV Prostate Adenocarcinoma Cancer AJCC v8

United States
Jeanne Link
Oregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center...

Approved for marketing

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic

United States
Ottawa Hospital Research Institute
Knight Therapeutics (USA) Inc

Recruiting

Dose Escalation For INtraprostatic LEsions (DEFINE)

Prostatic Neoplasms

Canada
University of Colorado, Denver
OHSU Knight Cancer Institute

Recruiting

Integrative Health Interventions in Symptom Management of Pediatric Patients

Cancer | Pediatric Cancer

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Lymphoma | Thrombocytopenia | Brain and Central Nervous System Tumors | Drug/Agent Toxicity by Tissue/Organ

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

Malignant Glioma | Metastatic Malignant Neoplasm in the Brain | Central Nervous System Lymphoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial) (GET FIT)

Malignant Neoplasm | Postmenopausal

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Contrast Enhanced MRI of the Prostate

Prostatic Neoplasms

United States

Clinical Trials Sponsored by Health Insight

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations